Correlation of EZH2 expression and response to chemoradiation in patients with locally advanced inoperable oral cavity and oropharyngeal squamous cell cancers
The study indicates that EZH2 can be a valuable predictive marker in HNC. Anti-EZH2 therapy should be explored to improve the treatment outcomes in patients with high expression of EZH2.
Authors
- Pradipta Kumar Parida (ORCID: https://orcid.org/0000-0002-7869-2866)
- Arnab Sarkar (ORCID: https://orcid.org/0000-0002-7354-2092)
- Anupam Muraleedharan (ORCID: https://orcid.org/0000-0002-0497-0181)
- D. Muduly
- Mathan Kumar Ramasubbu (ORCID: https://orcid.org/0000-0002-5047-7603)
- Deepak Das (ORCID: https://orcid.org/0000-0003-4039-9637)
- Ankur Mahajan
- Amit Kumar Adhya (ORCID: https://orcid.org/0000-0002-1860-4035)
- Saroj Kumar Das Majumdar (ORCID: https://orcid.org/0000-0001-7151-6539)
- Shaha Sheik Abdulla
- Phanindra Kumar Swain
- Nehla Haroon
- Sandip Kumar Barik
- S. K. Soel Ahmed
- Priyanka Mukherjee
- Dillip Kumar Parida
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
- Tata Memorial Hospital (IN)
- All India Institute of Medical Sciences Bhubaneswar (IN)
- Nference (India) (IN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-10-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_1467_25
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00